UBS AM
CELL

UBS AM’s PhenomeX Inc. Common Stock CELL Stock Holding History

UBS AM’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,937
Closed -$248K – 2787
2021
Q1 		$248K Hold
4,937
– – ﹤0.01% 2524
2020
Q4 		$441K Buy
+4,937
New +$415K ﹤0.01% 2332

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

UBS AM's CELL Position: Q2 2021 in Review

UBS AM sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2021, closing a stake of 4,937 shares — an estimated $248K sold.

UBS AM first reported a position in CELL in Q4 2020 and held it in 2 quarters. The position peaked at $441K in Q4 2020. 156 funds tracked by Wall St. Rank hold CELL as of Q2 2021.

  • UBS AM reported no remaining PhenomeX Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • UBS AM sold 4,937 PhenomeX Inc. Common Stock shares in Q2 2021, an estimated $248K.
  • UBS AM first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • UBS AM's PhenomeX Inc. Common Stock position peaked at $441K in Q4 2020.
  • 156 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2021.

Based on UBS AM's 13F filing for Q2 2021, filed 16 Aug 2021.